5-Year Clinical and Ultrasound Outcomes in CARENET Prospective Multicenter Trial of CGuard MicroNET Covered Carotid Stent
PublicationJ Am Coll Cardiol Intv. 2022 Sep, 15 (18) 1889–189
AuthorPiotr Musiałek, Adam Mazurek, Ralf Kolvenbach, Krzysztof Malinowski, Christina Brinkmann, Horst Sievert, and Joachim Schofer
FocusCARENET (CARotid Embolic Prevention using MicroNET-Covered Stent System in Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis) was the first multicentric, multispecialty, prospective single-arm trial of CGuard™. Clinical evaluation and duplex ultrasound imaging (30 days, 6 months, 1 and 5 years) were performed by an independent neurologist and a certified ultrasonographer.
In the CARENET trial population at 5 years follow up, the MicroNET-covered stent CGuard™ use was associated with:
• Sustained ipsilateral stroke prevention.
• A durable anatomical reconstruction of the carotid artery
• Absence of in-stent restenosis (normal healing)
• Absence of external carotid artery occlusion (uncompromised side-branch)